BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22486)

  • 1. Demonstration and characterization of a serum factor produced by activated T cells.
    Dardenne M; Bach JF
    Immunology; 1977 Nov; 33(5):643-51. PubMed ID: 22486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological status of nude mice engrafted with allogeneic or syngeneic thymuses.
    Furukawa F; Ikehara S; Good RA; Nakamura T; Inoue S; Tanaka H; Imamura S; Hamashima Y
    Thymus; 1988; 12(1):11-26. PubMed ID: 2977452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
    Janeway CA
    J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.
    Lonai P; Mogilner B; Rotter V; Trainin N
    Eur J Immunol; 1973 Jan; 3(1):21-6. PubMed ID: 4146225
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on thymus products. I. Modification of rosette-forming cells by thymic extracts. Determination of the target RFC sub-population.
    Dardenne M; Bach JF
    Immunology; 1973 Sep; 25(3):343-52. PubMed ID: 4542645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of transplantation tolerance in mice across major histocompatibility barrier by using allogeneic thymus transplantation and total lymphoid irradiation.
    Waer M; Palathumpat V; Sobis H; Vandeputte M
    J Immunol; 1990 Jul; 145(2):499-504. PubMed ID: 2142180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory factors in human serum: effect on murine T cells.
    Skibiński G; Wieczorek Z; Zwoliński J
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):9-19. PubMed ID: 6974547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of bispecific rosette-forming cells. I.--Presence of T-lymphocyte markers.
    Martin-Taieb C; Liacopoulos P; Bach JF
    Ann Immunol (Paris); 1975 Apr; 126(3):291-301. PubMed ID: 52332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K; Gondo H; Nomoto K
    J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
    Budhecha S; Hamilton BL
    J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique.
    Kops SK; Ratzlaff RE; Meade R; Iverson GM; Askenase PW
    J Immunol; 1986 Jun; 136(12):4515-24. PubMed ID: 2423595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of bispecific rosette-forming cells. II. --Rosette formation by "educated" T-lymphocytes.
    Birrien JL; Martin-Taieb C; Bach JF; Liacopoulos P
    Ann Immunol (Paris); 1975 Apr; 126(3):303-17. PubMed ID: 52333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
    Piazzon I; Déroche A; Matusevich M; Pasqualini CD
    Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
    [No Abstract]   [Full Text] [Related]  

  • 17. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic surface determinants of chicken lymphoid cells. II. Selective in vivo and in vitro activity of anti-bursa and anti-thymus sera.
    Wick G; Albini B; Johnson W
    Immunology; 1975 Feb; 28(2):305-13. PubMed ID: 47306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of T and B lymphocytes in vitro. IV. Regulatory influence on specific T cell functions by a thymus extract factor.
    Armerding D; Katz DH
    J Immunol; 1975 Apr; 114(4):1248-54. PubMed ID: 1090671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.